Energy-Metabolism-Enhancing Probiotics Enhance the Therapeutic Response to a Glucagon-like Peptide-1 Receptor Agonist
Nutrients · 2026
DOI: 10.3390/nu18071050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von A-Ram Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute, GI Longevity Inc., Seongnam 13201, Republic of Korea. Hauptthemen laut MEDLINE: Probiotics, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptides, Energy Metabolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Korea Health Industry Development Institute https://ror.org/00fdzyk40.
Abstract (Originalsprache)
Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective treatments for obesity, but substantial weight regain is common after therapy is discontinued. This study investigated whether probiotic strains with anti-obesity effects could enhance GLP-1RA-induced weight loss and attenuate post-treatment weight rebound.
Methods
Candidate lactic acid bacteria were screened for anti-obesity efficacy in a high-fat-diet (HFD)-induced obese mouse model, and the selected strain was further characterized using metabolomic profiling of culture supernatants. To examine its interaction with GLP-1RA therapy, obese mice received dulaglutide for 4 weeks and were monitored for 2 weeks after treatment withdrawal, while the probiotic was orally administered for a total of 6 weeks. Body weight, glycemic parameters, and muscle strength were assessed throughout the study.
Results
Limosilactobacillus fermentum GB102 reduced body weight and improved glycemic control in HFD-fed mice. These metabolic benefits were associated with alterations in circulating metabolic hormones, including adipokines, along with attenuated inflammatory responses in adipose tissue. Metabolomic profiling revealed that GB102 produced high levels of succinic acid, a metabolite previously linked to thermogenic activation. This strain increased whole-body energy expenditure in HFD-fed mice, produced glutamine, and showed enhanced conversion of arginine into ornithine and citrulline. When combined with dulaglutide, GB102 enhanced weight loss, preserved muscle strength, and attenuated both weight regain and glycemic rebound following dulaglutide withdrawal.
Conclusions
These findings suggest that energy-metabolism-enhancing probiotics such as GB102 may enhance the metabolic effects of GLP-1RA therapy and help attenuate weight regain after treatment discontinuation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute, GI Longevity Inc., Seongnam 13201, Republic of Korea.
- Mediogen Inc., Jecheon 27159, Republic of Korea.
- Mucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul 05505, Republic of Korea.
- Digestive Diseases Research Center, University of Ulsan College of Medicine/Asan Medical Center, Seoul 05505, Republic of Korea.
- World Premier International Immunology Frontier Research, Osaka University, Suita 565-0871, Japan.
- Research Institute, GI Innovation Inc., Seoul 05855, Republic of Korea.
ORCID-Profile: A-Ram Kim, Bo-Gie Yang
Förderung
- Korea Health Industry Development Institute
- Korea Health Industry Development Institute https://ror.org/00fdzyk40
Zitieren
APA
Kim, A. R., Jeon, S. G., Park, S. J., Kim, B. K., Kweon, M. N., Jang, M. H., & Yang, B. G. (2026). Energy-Metabolism-Enhancing Probiotics Enhance the Therapeutic Response to a Glucagon-like Peptide-1 Receptor Agonist. Nutrients. https://doi.org/10.3390/nu18071050
Vancouver
Kim AR, Jeon SG, Park SJ, Kim BK, Kweon MN, Jang MH, et al. Energy-Metabolism-Enhancing Probiotics Enhance the Therapeutic Response to a Glucagon-like Peptide-1 Receptor Agonist. Nutrients. 2026. doi:10.3390/nu18071050
BibTeX
@article{Kim2026,
author = {Kim, A-Ram and Jeon, Seong-Gak and Park, So-Jung and Kim, Byoung-Kook and Kweon, Mi-Na and Jang, Myoung Ho and Yang, Bo-Gie},
title = {Energy-Metabolism-Enhancing Probiotics Enhance the Therapeutic Response to a Glucagon-like Peptide-1 Receptor Agonist},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18071050}
}
EUVIMED